Literature DB >> 25689951

Osthole inhibits inflammatory cytokine release through PPARα/γ-mediated mechanisms in LPS-stimulated 3T3-L1 adipocytes.

Xiao-li Wang1, Xiang Shang, Yan Cui, Xi Zhao, Yan Zhang, Mei-lin Xie.   

Abstract

CONTEXT: Peroxisome proliferator-activated receptor (PPAR) α/γ may control inflammatory response by regulating the nuclear factor-kappa B (NF-κB). Osthole may be a dual agonist of PPARα/γ, but whether or not osthole may inhibit inflammatory cytokines in cultured 3T3-L1 adipocytes is unclear.
OBJECTIVE: We investigated the action of osthole and its potential mechanisms in lipopolysaccharide (LPS)-stimulated 3T3-L1 adipocytes.
MATERIALS AND METHODS: The 3T3-L1 adipocytes stimulated with LPS were cultured and treated with different concentrations of osthole. The inflammatory cytokines including tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in cultured supernatants were detected by the enzyme-linked immunosorbent assay (ELISA) method, and the protein expressions of PPARα/γ and NF-κB p65 in adipocytes were detected by the Western blot method, respectively.
RESULTS: Following treatment of adipocytes with osthole 0.1-1.6 μM, the TNF-α and IL-6 levels in cultured supernatants were decreased, and the NF-κB p65 protein expression in adipocytes was also decreased, while the PPARα/γ protein expressions were increased. After pretreatment of adipocytes with specific inhibitor(s) of PPARα and /or PPARγ, the inhibitory effects of osthole on TNF-α and IL-6 were decreased or almost cancelled, and the effects on NF-κB p65 protein expression also exhibited similar variations.
CONCLUSION: Osthole could inhibit the TNF-α and IL-6 production in LPS-stimulated adipocytes, and its mechanism might be related to reduction of NF-κB expression via activation of PPARα/γ.

Entities:  

Keywords:  3T3-L1 adipocytes; IL-6; PPARα/γ; TNF-α; osthole

Mesh:

Substances:

Year:  2015        PMID: 25689951     DOI: 10.3109/08923973.2015.1009997

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  5 in total

1.  Duhuo Jisheng Decoction inhibits SDF-1-induced inflammation and matrix degradation in human degenerative nucleus pulposus cells in vitro through the CXCR4/NF-κB pathway.

Authors:  Zong-Chao Liu; Zhen-Long Wang; Chen-Yi Huang; Zhi-Jiang Fu; Yong Liu; Zhang-Chao Wei; Shi-Gui Liu; Chuan Ma; Jie-Liang Shen; Dayue Darrel Duan
Journal:  Acta Pharmacol Sin       Date:  2018-05-24       Impact factor: 6.150

2.  Inhibition of osteolysis after local administration of osthole in a TCP particles-induced osteolysis model.

Authors:  Shumin Lv; Yun Zhang; Ming Yan; Hongjiao Mao; Cailing Pan; Mingxiao Gan; Jiawen Fan; Guoxia Wang
Journal:  Int Orthop       Date:  2015-10-26       Impact factor: 3.075

3.  Du-Huo-Ji-Sheng-Tang Attenuates Inflammation of TNF-Tg Mice Related to Promoting Lymphatic Drainage Function.

Authors:  Yan Chen; Jinlong Li; Qiang Li; Tengteng Wang; Lianping Xing; Hao Xu; Yongjun Wang; Qi Shi; Quan Zhou; Qianqian Liang
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-27       Impact factor: 2.629

4.  Ameliorative Effects of Osthole on Experimental Renal Fibrosis in vivo and in vitro by Inhibiting IL-11/ERK1/2 Signaling.

Authors:  Fan Wu; Yan Zhao; Qingqing Shao; Ke Fang; Ruolan Dong; Shujun Jiang; Fuer Lu; Jinlong Luo; Guang Chen
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

5.  Osthole Blocks HMGB1 Release From the Nucleus and Confers Protective Effects Against Renal Ischemia-Reperfusion Injury.

Authors:  Qing Dai; Deqiong Xie; Chenli Zhang; Lei Zhu; Ying Xu; Kui Li; Wen Hao; Hefei Yin
Journal:  Front Physiol       Date:  2021-12-22       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.